FDA's new efforts to advance antimicrobial stewardship in veterinary settings

FDA Commissioner Scott Gottlieb, MD, announced Tuesday plans for a new, 5-year blueprint for how the agency will advance antimicrobial stewardship in veterinary settings. The goal, he said, is to cut back on overuse of antimicrobial drugs and fight the increasing threat of resistance.

FDA Commissioner Scott Gottlieb, MD, announced Tuesday plans for a new, 5-year blueprint for how the agency will advance antimicrobial stewardship in veterinary settings. The goal, he said, is to cut back on overuse of antimicrobial drugs and fight the increasing threat of resistance. The blueprint will include key goals, objectives, and actions that FDA's Center for Veterinary Medicine will focus on in fiscal years 2019 through 2023. The new actions will focus on three main objectives: aligning antimicrobial drug product use with the principles of antimicrobial stewardship; supporting efforts to foster better stewardship of antimicrobials in veterinary settings; and enhancing the monitoring of antimicrobial resistance and antimicrobial drug use in animals. More specific aims and actions will be detailed in the upcoming plan. According to Gottlieb, "Some of the important issues to be addressed in this new plan include establishing appropriate durations of use of medically important antimicrobials, and bringing all dosage forms of medically important antimicrobials under veterinary oversight. We are also developing and advancing new strategies for promoting antimicrobial stewardship in companion animals."